AMN vs MD

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 20, 2026

AMN

42.1
AI Score
VS
AMN Wins

MD

37.6
AI Score

Investment Advisor Scores

AMN

42score
Recommendation
HOLD

MD

38score
Recommendation
AVOID NEW MONEY

AI Analyst Insights

Detailed Metrics Comparison

Metric AMN MD Winner
Forward P/E 18.018 9.2937 MD
PEG Ratio 1.7113 0.2433 MD
Revenue Growth 2.3% 4.0% MD
Earnings Growth 321.3% 6.5% AMN
Tradestie Score 42.1/100 37.6/100 AMN
Profit Margin 3.1% 9.0% MD
Beta 1.00 1.00 Tie
AI Recommendation HOLD AVOID NEW MONEY AMN

Relative Price Performance (Last 90 Days)

AMN 1M: +24.6% · 3M: +30.1% MD 1M: +6.6% · 3M: +9.8%

Current Technical Phase

AMN

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (4.0% over 20 days), RSI 82

RSI (14): 81.8 · Price: $43.02

MD

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (0.6% over 20 days), RSI 66

RSI (14): 66.1 · Price: $28.09

Fundamentals Snapshot

Metric AMN MD
Market Cap — —
Forward P/E 44.3 11.5
Trailing P/E 15.1 13.1
Revenue (TTM) — —
Revenue Growth 0.0% 0.0%
Gross Margin 0.3% 0.3%
Operating Margin 0.0% 0.1%
EPS 2.68 2.08
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, AMN is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.